0.70Open0.70Pre Close0 Volume20 Open Interest77.50Strike Price0.00Turnover100.08%IV37.60%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type0.1176Delta0.0147Gamma81.19Leverage Ratio-0.0654Theta0.0033Rho9.54Eff Leverage0.0264Vega
Molson Coors Beverage Stock Discussion
$EOG Resources (EOG.US)$ $FS KKR Capital (FSK.US)$ $Molson Coors Beverage (TAP.US)$ $CF Industries Holdings (CF.US)$ $The Mosaic (MOS.US)$ $YIELDMAX NVDA OPTION INCOME STRATEGY ETF (NVDY.US)$
$Waters (WAT.US)$ $Molson Coors Beverage (TAP.US)$ $Anheuser-Busch Inbev (BUD.US)$ $Coca-Cola (KO.US)$ $Xylem (XYL.US)$ $ThaiBev (Y92.SG)$ $Lennar Corp (LEN.US)$ $D.R. Horton (DHI.US)$ $PepsiCo (PEP.US)$ $3M (MMM.US)$ $Applied Materials (AMAT.US)$ $Netflix (NFLX.US)$ $Advanced Micro Devices (AMD.US)$ $Lululemon Athletica (LULU.US)$
Morgan Stanley anticipated annual global sales for weight-loss drugs could reach $77 billion by 2030, higher than its previous $54 billion forecast. $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ will spli...
No comment yet